June 28, 2025 – Wuhan, China – Landing Med, a global leader in AI-powered cervical cytology screening, has been named one of the Top 50 AI Technology Enterprises in China by Forbes China. The announ...
On May 11, 2025, the 2025 Forbes China Top 50 Artificial Intelligence Technology Companies list was officially released. Landing Med earned a coveted position on the list, standing out as the only com...
From May 11 to 15, 2025, the 22nd International Congress of Cytology (ICC) was held in Florence, Italy—a historic city rich in cultural heritage. Organized by the International Academy of Cytology (I...
On April 11, 2025, the Landing–Iraq AI Cervical Cancer Screening Strategic Cooperation Signing Ceremony was successfully held at Landing Med's headquarters.
Singapore – March 21, 2025 – Landing Med, a global leader in AI-driven cervical cytology screening, has been awarded first prize for its scientific abstract “Artificial Intelligence Cytological Scr...
Landing Med was named a 2024 Top Innovative Healthcare Company by Forbes China, recognizing its groundbreaking AI-powered cervical cancer screening solutions. Its scalable technology has enhanced screening access for 11+ million women, particularly in underserved areas.
Seoul, South Korea – October 2-4, 2024Landing Med’s Chief Technology Officer (CTO), Dr. Pang Baochuan, was invited to speak at the inaugural Asia Society of Digital Pathology Congress in Seoul, Sout...
Florence, Italy – Landing Med highlighted its groundbreaking technologies at the 2024 European Congress of Pathology (ECP) in Florence, Italy, from September 7-11, showcasing advancements in digital ...
Lusaka, Zambia – July 16-19, 2024Landing Med, a trailblazer in health technology, has been recognized as the only Asian company invited to participate in the prestigious Ending Preventable Maternal M...
Vilnius, Lithuania – Landing Med’s Founder and Chairwoman, Dr. Xiaorong Sun, was honored to be invited to speak at the prestigious European Congress of Digital and Spatial Pathology (ECDP) in Vilniu...